Please provide your email address to receive an email when new articles are posted on . Among patients with T1 colorectal cancer, deep submucosal invasion was not a significant independent predictor ...

More than 10 years have passed since endoscopic submucosal dissection (ESD) was first developed in Japan. ESD enables en bloc complete resection of superficial gastrointestinal neoplasms regardless of ...

Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Compared to minimally invasive surgery, endoscopic submucosal dissection (ESD) represents an advanced, less-invasive endoscopic treatment for early gastrointestinal cancer. ESD has significant ...

For patients with large benign colonic lesions, endoscopic submucosal dissection (ESD) is associated with reduced recurrence at six months compared with endoscopic mucosal resection (EMR), according ...

The saline-immersion/irrigation technique (SITE) in colorectal endoscopic submucosal dissection (ESD), combined with the pocket-creation method (PCM), showed curative ...

Submucosal fibroids are benign tumors that can cause heavy menstrual bleeding. Hormonal fluctuations and family history can ...

Researchers examine curcumin's therapeutic power against oral submucosal fibrosis, revealing its potential to reduce inflammation, fibrosis, and cancer risks in this precancerous oral condition. Study ...

A phase II, open-label, randomized study to evaluate the efficacy and safety of andecaliximab combined with nivolumab versus nivolumab alone in subjects with unresectable or recurrent gastric or ...

Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and ...